Mol Microbiol 2003,48(6):1511–1524.PubMedCrossRef 27. Barken KB, Pamp SJ, Yang L, Gjermansen M, Bertrand JJ, Klausen M, Givskov M, Whitchurch CB, Engel JN, Tolker-Nielsen T: Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms. Environ Microbiol 2008,10(9):2331–2343.PubMedCrossRef 28. Ruer S, Stender S, Filloux A, de Bentzmann S: Assembly of fimbrial structures in Pseudomonas aeruginosa: functionality and specificity of chaperone-usher machineries. J Bacteriol 2007,189(9):3547–3555.PubMedCrossRef 29. Giraud C, Bernard CS, Calderon V, Yang L, Filloux A, Molin S, Fichant

G, Bordi GSK-3 inhibitor C, de Bentzmann S: The PprA-PprB two-component system activates CupE, the first non-archetypal Pseudomonas

aeruginosa chaperone-usher pathway system assembling fimbriae. Environ Microbiol 2011,13(3):666–683.PubMedCrossRef 30. Garrett ES, Perlegas D, Wozniak DJ: Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU). J Bacteriol 1999,181(23):7401–7404.PubMed 31. Tart AH, Wolfgang MC, Wozniak DJ: The alternative sigma factor AlgT represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of fleQ. J Bacteriol 2005,187(23):7955–7962.PubMedCrossRef 32. Tart AH, Blanks MJ, Wozniak DJ: The AlgT-dependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic {Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|buy Anti-infection Compound Library|Anti-infection Compound Library ic50|Anti-infection Compound Library price|Anti-infection Compound Library cost|Anti-infection Compound Library solubility dmso|Anti-infection Compound Library purchase|Anti-infection Compound Library manufacturer|Anti-infection Compound Library research buy|Anti-infection Compound Library order|Anti-infection Compound Library mouse|Anti-infection Compound Library chemical structure|Anti-infection Compound Library mw|Anti-infection Compound Library molecular weight|Anti-infection Compound Library datasheet|Anti-infection Compound Library supplier|Anti-infection Compound Library in vitro|Anti-infection Compound Library cell line|Anti-infection Compound Library concentration|Anti-infection Compound Library nmr|Anti-infection Compound Library in vivo|Anti-infection Compound Library clinical trial|Anti-infection Compound Library cell assay|Anti-infection Compound Library screening|Anti-infection Compound Library high throughput|buy Antiinfection Compound Library|Antiinfection Compound Library ic50|Antiinfection Compound Library price|Antiinfection Compound Library cost|Antiinfection Compound Library solubility dmso|Antiinfection Compound Library purchase|Antiinfection Compound Library manufacturer|Antiinfection Compound Library research buy|Antiinfection Compound Library order|Antiinfection Compound Library chemical structure|Antiinfection Compound Library datasheet|Antiinfection Compound Library supplier|Antiinfection Compound Library in vitro|Antiinfection Compound Library cell line|Antiinfection Compound Library concentration|Antiinfection Compound Library clinical trial|Antiinfection Compound Library cell assay|Antiinfection Compound Library screening|Antiinfection Compound Library high throughput|Anti-infection Compound high throughput screening| fibrosis isolates. J Bacteriol 2006,188(18):6483–6489.PubMedCrossRef 33. Liu Y, Yang L, Molin S: Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation. Antimicrob Agents Chemother 2010,54(9):3960–3963.PubMedCrossRef 34. Wu HY, Zhang XL, Pan Q, Wu J: Functional selection of a type IV pili-binding peptide that specifically inhibits

Salmonella Typhi adhesion to/invasion of human monocytic cells. Peptides 2005,26(11):2057–2063.PubMedCrossRef HA-1077 solubility dmso 35. Holloway BW, Morgan AF: Genome organization in Pseudomonas. Annu Rev Microbiol 1986, 40:79–105.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions LY (Lei) carried out the first batch of microarray studies. MR carried out the second batch of microarray studies. LY (Liang) carried out the microarray data analysis and wrote the manuscript. NH provided the strains for the study. SM and LJ participated in the design of the study and helped to draft the manuscript. All authors read and approved the final manuscript.”
“Background Nontypeable (non encapsulated) Haemophilus influenzae is an exclusively human pathogen whose primary ecological niche is the human respiratory tract. H.